CD274 and glioblastoma: In GBM models, the nanoparticles remodeled the tumor microenvironment from “cold” to “hot”, enhancing the efficacy of anti-PD-L1/anti-PD-1 therapy by promoting macrophage polarization and activating cytotoxic T lymphocytes (CTL) and dendritic cells (DC).